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Previewstrigger the DC activation response? For
one thing, white blood cells injected alone
were apparently unable to evoke CD4+
DC activation, as shown, but more inves-
tigation is needed to further substantiate
that RBCs are both essential (platelets?
white cell contribution?) and sufficient
(highly purified RBCs?) for this. The cur-
rent work certainly deserves credit for
providing the inspiration to perform such
studies.
Another question relates to the issue of
‘‘missing self.’’ Clearly, this concept is
well known for MHC class I molecules
that can be downregulated under various
pathological conditions, such as infection
with large DNA viruses. However, is this
also the case for CD47 on RBCs? And if
so, could this then be a mechanism to
engage erythrocytes in promoting immu-
nity by delivering danger signals to DCs?
Actually, we do not really know at this
point whether missing CD47 occurs at
all, for instance, during infections of the
erythrocyte, and, if this does occur,
whether it plays a critical and meaningful
role. Clearly, one condition that springs
to mind when considering erythrocytes
as a target for infection is malaria. Howev-624 Immunity 43, October 20, 2015 ª2015 Eler, evidence so far has not revealed any ef-
fects of RBC Plasmodium infection on
CD47 overall expression (Hempel et al.,
2014). What is interesting nevertheless is
that CD47 deficiency confers resistance
to malaria infection (Banerjee et al.,
2015), and the current work by Yi et al.
might also provide a potential explanation
for that.
Finally, there is the situation in humans.
It is known that the human spleen has
quite a different architecture than the ro-
dent spleen, and this is particularly
evident in the marginal-zone area. In
fact, a marginal zone is not clearly identifi-
able in the human spleen (Steiniger,
2015). Nevertheless, the perifollicular
zone of the human spleen, which also
contains a subset of DCs, has been sug-
gested to resemble, at least in some as-
pects, the rodent marginal zone (Pack
et al., 2008). It would obviously be of inter-
est to find out whether this novel and
exciting concept of RBC-mediated con-
trol over DC activation also occurs in hu-
mans. Be that as it may, Yi and colleagues
have certainly demonstrated that DCs see
red when encountering erythrocytes that
are denuded of CD47.sevier Inc.REFERENCES
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Long studied as modulators of insulin sensitivity, adipose tissue immune cells have recently been implicated
in regulating fat mass and weight gain. In this issue of Immunity, Reisner and colleagues (2015) report
that ablation of perforin-expressing dendritic cells induces T cell expansion, worsening autoimmunity and
surprisingly increasing adiposity.The immune and metabolic systems are
tightly coupled so that substantial
changes in one often alter the function
and state of the other. In adipose tissue
(AT), where these two systems interact
intimately, increases or decreases in fat
mass elicit cellular immune responses
that can increase or decrease immune
cell populations by as much as an order
of magnitude, so that in the most obeseindividuals immune cells constitute the
majority of cells in a fat depot. Conversely,
perturbations in immune cell number and
function can increase or reduce the effi-
ciency of adipocyte lipid storage, and
thereby alter systemic glucose and lipid
metabolism. Sub-populations of adipose
tissue macrophages (ATMs) and T cells
have been the most intensively studied
but eosinophils, mast cells, neutrophils,and iNKT cells also respond to changes
in the metabolic state of adipose tissue
and have been implicated in modulating
local inflammation and systemic meta-
bolism. A simple paradigm has emerged
from early studies suggesting that
changes in immune function and profiles
that skew toward a type 1 cellular immune
response impair adipocyte function and
induce systemic insulin resistance.
Figure 1. Deficiency of Perforin+ DCs Leads to Expansion of T Cell Populations and Adipose
Tissue Mass
The mixed marrow transplant design employed by Reisner and colleagues allows comparison of WT-
Prf1/mice in which 50% of hematopoietic cells lack perforin (left panel) and Itgax-DTA- Prf1/mice in
which all CD11c+ (Itgax+) cells lack perforin (right panel). In the Itgax-DTA-Prf1/mouse (right panel), their
adipose tissue has an increase in T lymphocytes and M1 macrophages and is enlarged compared to
adipose tissue (left panel) where half of all hematopoietic cells in WT-Prf1/ mouse lack perforin.
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PreviewsRecent studies, however, have uncov-
ered a more direct role for immune cells
in adipocyte metabolism, a role indepen-
dent of inflammation and in which lipid
catabolism, especially by ATMs, regulate
whole adipose tissue and body lipidmeta-
bolism. The catabolism of excess lipids by
ATMs contributes directly to lipid fluxes
through fat and into the circulation (Xu
et al., 2013). Separately, genetic and
pharmacologic studies that target im-
mune cells function have uncovered
another unexpected role for the immune
system in adipose tissue biology. In im-
mune cells, fat mass is modulated by tar-
geted deletion or inhibition of nuclear
receptors, surface receptors that regulate
immune cell activation and recruitment,
and inflammatory regulators. However,
despite the identification of some immune
molecules that can regulate fat mass, the
cells responsible and the mechanisms
remain completely obscure. Reisner and
colleagues now identify a population of
perforin+ dendritic cells (Perf-DCs) (Zlotni-
kov-Klionsky et al., 2015) whose function
contributes to adipose tissue expansion.
Previously, the Reisner laboratory
defined a population of dendritic cells
that in vitro kill CD8+ T cells recognizingpeptide-major histocompatibility com-
plex (MHC) molecules in a process that
employs perforin, a canonical cytotoxic
polypeptide (Zangi et al., 2012). They
had hypothesized that these cells would
function in a tolerogenic fashion, limiting
immune and inflammatory responses
in vivo. Using a clever method to generate
mice that lack perforin in CD11c+ cells,
the authors demonstrated a role for
Perf-DCs in the experimental autoimmune
encephalomyelitis (EAE) model of multiple
sclerosis and perhapsmore surprisingly in
regulating adipose tissue inflammation
and mass.
The elimination of perforin-expressing
dendritic cells was carried out by
transplanting irradiated wild-type mice
with mixed marrow from two donors:
Perforin-deficient (Prf1/) and Itgax-DTA
mice. Immune cells arising from Itgax-
DTA marrow expressed the lethal diph-
theria toxin A under the Itgax (Cd11c) pro-
moter. Thus, all CD11c+ leukocytes in the
Itgax-DTA;Prf1/ chimeras derive from
the Prf1/ donor (Figure 1). One caveat
of this approach is that approximately
half of the non-CD11c+ cells immune cells
are also deficient in perforin. Given that
CD8+ T cell homeostasis is in part depen-Immunity 43dent on perforin (Badovinac et al., 2000),
this partial deficiency of perforin in non-
targeted populations might alter the ho-
meostasis and clonality of somesubpopu-
lations, includingcytotoxic T lymphocytes.
Consistent with in vitro observations
and Perf-DCs playing a tolerogenic
role, mice lacking Perf-DCs proved more
susceptible to experimental autoimmune
encephlalomyelitis (EAE); developing dis-
ease earlier and with greater severity.
Unexpectedly, however, mice deficient
in Perf-DCs also developed a metabolic
phenotype while eating a low-fat diet in
the absence of any experimental immune
stimulus. Three months after transplant,
mice fed a low-fat diet and lacking Perf-
DCs gained significantly more weight
than control mice with Perf-DCs intact.
The weight gain was due to expansion of
fat mass and adipocyte hypertrophy, and
consistent with the increased adiposity,
the Perf-DC-deficientmiceweremetabol-
ically dysregulated with increased insulin
resistance and impaired glucose toler-
ance. These findings echo the metabolic
phenotype of mice lacking Perforin
(Prf1/) in all cells. Mice lacking Prf1
weigh more than their littermate controls
early in life, though by 26 weeks of age
the weight of the Prf1/ mice catches
up to that of control animals (Revelo
et al., 2015). The obesity phenotype of
Perf-DC-deficient mice was further exac-
erbated when they were fed a high-fat
diet; animals deficient in Perf-DCs
became more obese when fed a high-fat
diet than mice replete with Perf-DCs.
This unexpected result led the authors to
study the immune cell populations of adi-
pose tissue.
On the basis of their previous in vitro
data, the authors hypothesized Perf-DCs
act to regulate the quantity of T cells in ad-
ipose tissue and limit their expansion.
Indeed, deficiency of Perf-DCs increased
the populations of CD4+ and CD8+ T cells
in fat of Itgax-DTA; Prf1/mice. Remark-
ably, depletion of T cells in the Perf-DCs
not only normalized the AT T cell popula-
tion but also prevented the development
of obesity. If their model is correct, then
these data imply a restriction of the
T cell receptor (TCR) repertoire in normal
adipose tissue to which Perf-DCs
contribute. A restricted adipose tissue
TCR repertoire in lean mice has been re-
ported by others, both in regulatory
T cells (Feuerer et al., 2009) and CD8+, October 20, 2015 ª2015 Elsevier Inc. 625
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PreviewsT cells (Nishimura et al., 2009), and Reis-
ner and colleagues corroborate this.
Through deconvolution of variance be-
tween groups, the authors identified
TCR-b sequences which were enriched
in AT of mice lacking Perf-DCs. Several
of the identified TCR-b sequences varied
at the nucleotide level while encoding
synonymous codons. Enticingly, this im-
plies Perf-DCs constrain T cell clones,
which recognize specific antigen(s) pre-
sent in AT.
The authors conclude that deletion of
populations of T cells in adipose tissue
helps limit fat mass expansion. This
is a provocative hypothesis and wholly
consistent with their data. However, it rai-
ses several further lines of questions for
which their model does not provide an-
swers. From an immunological perspec-
tive, what are the postulated antigens?
From where are they derived? Are they
adipocyte or even foreign derived?
Answering these questions would un-
doubtedly reveal a fundamental aspect
of the relationship between adipose tis-
sue and the immune system and likely
shed light on why there is such a robust
immune response in adipose tissue.626 Immunity 43, October 20, 2015 ª2015 ElThese findings also do not address the
nature of the signal that causes an in-
crease in fat mass in Perf-DC-deficient
mice. Though incompletely understood,
the regulation of fat mass is under neuro-
endocrine control, with hormones, most
notably leptin being released from adi-
pose tissue, signaling to the feeding and
energy regulatory centers of the central
nervous system. How does deletion or
expansion of T cells alter this homeostatic
loop? It is conceivable that the weight
regulatory effects of Perf-DCs might not
be limited or even found in the adipose
tissue.
Although the immune response to
metabolic perturbations is most robust
in adipose tissue, metabolically induced
and specifically obesity induced changes
in immune populations also occur in other
important tissues, including the liver,
intestine, pancreas, and hypothalamus.
Indeed, perhaps the most parsimonious
explanation for the current observations
is that Perf-DCs limit T cell populations
in the hypothalamus or brainstem in
ways that locally modulate neurons crit-
ical for feeding behavior, satiety and en-
ergy expenditure. Answering these ques-sevier Inc.tions will provide key, fundamental
insights into both metabolism and
immunology.REFERENCES
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Food-specific IgE is central to the pathobiology of food allergy, but not sufficient to induce disease. Chen
et al. (2015) demonstrate that food-elicited reactions require an immature mast cell that generates IL-9 to
induce its own maturation.Acute allergic reactions to foods can
range in severity from mild mouth itching
or abdominal discomfort to severe life-
threatening anaphylaxis. Because there
is no cure or disease-modifying therapy,
the management of food allergic patients
is limited to the use of epinephrine for
accidental ingestions and the strict avoid-ance of diagnosed food allergens. This
prescription is complicated by the finding
of elevated food-specific immunoglobulin
E (IgE), indicative of sensitization, in indi-
viduals with no clinical reaction to
the implicated food. Indeed, although
approximately 8% of U.S. children are
sensitized to peanut, the prevalence ofclinical allergy is approximately 1%–2%
(Liu et al., 2010). The factors that regulate
clinical reactions to food antigens have
been sought for some time but are poorly
understood.
The natural history of repeated oral an-
tigen administration in mice and humans
is the generation of antigen-specific
